Rebalix
Logo XtrackersXtrackers · sheet of 10 September 2026
ETF sheet · official issuer and register data

Xtrackers Sli UCITS ETF 1d

LU0322248146 · LU0322248146 · CHF · domicile Luxembourg
Equity · SwitzerlandSFDR art. 6 (inferred)
Index tracked: SLI® SWISS LEADER INDEX (CHF)
TER
0.25%+ trans. 0.00%
Fund size
518 m EUR
Tracking difference
−1.22%3-year avg
🇮🇹 tax rate
white list not published
Replication
Physical
Income
Distributingsemi-annual
Launch 25 Jan 2008 · costs from the KID as of 2 Sept 2026 · 33 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The fund is passively managed. INVESTMENT OBJECTIVE: The aim is for your investment to reflect the performance of the SLI Swiss Leader index® (index) which is designed to reflect the performance of shares of the 30 largest and most traded companies listed on the SIX Swiss Exchange (other than investment companies). DESCRIPTION OF INDEX: The companies are selected on the basis that they have the largest combined value of readily available shares as compared to other companies on the stock exchange. A company’s weighting in the index depends on its…

Performance since series start (in euro) — base 100

25 Jan 20088 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
20092012201520182021202449460475
High 494 (2 Jul 2026) · low 60 (2 Mar 2009) · last 475. Past performance is not indicative of future results.

Returns in euro

1 year+13.4%
3 years+40.3%
5 years+41.9%
10 years+150.2%
Since series start+374.6%

Risk · 1 / 3 / 5 years

Volatility (ann.)11.57%12.83%14.35%
Max drawdown−11.00%−17.61%−28.13%
Sharpe0.860.540.08
Sortino1.240.730.11
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · LU0322248146 · LU03222481461
RebalixLU0322248146 · LU0322248146 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+13.88%+15.08%−1.21%
2024+9.80%+10.97%−1.17%
2023+10.47%+11.76%−1.29%
2022−19.31%−18.41%−0.90%
2021+24.89%+26.15%−1.26%

Distributions · per share, in CHF

Frequency: semi-annual · last 12 months: 3.3615 CHF (1.42% of NAV) · last ex-date 19 Aug 2026
YearPaymentsTotal (CHF)Dividend yield
202613.3615
202523.1169+1.56%
202422.847+1.55%
202313.1685+1.87%
202225.3847+2.49%
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.

Holdings

Portfolio as declared by the issuer · 2 Sept 2026 · 33 securities · top-10 weight = 61.2%
Top holdingsWeight
UBS GROUP AG9.8%
NOVARTIS AG9.0%
ROCHE PS PAR AG8.9%
NESTLE SA8.3%
COMPAGNIE FINANCIERE RICHEMONT SA4.5%
ZURICH INSURANCE GROUP AG4.4%
SWISS RE AG4.3%
LONZA GROUP AG4.1%
ABB LTD4.0%
HOLCIM LTD AG3.9%
Countries (% of fund)
Switzerland98.1%United States1.9%
Sectors (% of fund)
Financials25.9%Health Care21.4%Industrials18.3%Consumer Staples9.1%Consumer Discretionary4.5%

Listing venues

ESMA register (FIRDS) and official exchange lists
· Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange
XSLI · Xetra (Deutsche Börse)
+ 19 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · etf.dws.com/download/asset/6f05a05c-acd8-4ebe-8153-4e2d517740fe
Factsheet · etf.dws.com/download/asset/9613a41f-8864-4e20-8258-299c2cbd3d06
Prospectus · etf.dws.com/download/asset/97f28cea-2f24-445d-b135-f9c31a5f884d
The live sheet, always up to date
rebalix.com/en/etf/LU0322248146
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · LU0322248146 · LU03222481462